{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T13:24:49Z","timestamp":1786973089762,"version":"build-2736575974"},"reference-count":157,"publisher":"MDPI AG","issue":"8","license":[{"start":{"date-parts":[[2026,8,15]],"date-time":"2026-08-15T00:00:00Z","timestamp":1786752000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Antibiotics"],"abstract":"<jats:p>Carbapenem-resistant Enterobacterales (CRE) represent one of the most important antimicrobial resistance threats in Europe, particularly in healthcare settings. Their increasing epidemiological significance is driven by the dissemination of carbapenem-resistant Klebsiella pneumoniae, the emergence of high-risk clones, horizontal transfer of mobile genetic elements, and the convergence of antimicrobial resistance and hypervirulence. Despite the growing epidemiological importance of CRE, surveillance and preparedness remain heterogeneous across European countries, creating a need for a continent-wide assessment of existing surveillance systems, implementation gaps, and emerging challenges. This narrative review summarizes the current epidemiology of CRE in Europe and critically discusses the role of European and global surveillance systems in monitoring their spread. Particular attention is given to the European Antimicrobial Resistance Surveillance Network (EARS-Net), European Antimicrobial Resistance Genes Surveillance Network (EURGen-Net), Healthcare-Associated Infections Surveillance Network (HAI-Net), European Surveillance of Antimicrobial Consumption Network (ESAC-Net), Point Prevalence Survey (PPS), EpiPulse\/TESSy, the Central Asian and European Surveillance of Antimicrobial Resistance (CAESAR) programme, and the World Health Organization Global Antimicrobial Resistance and Use Surveillance System (WHO GLASS). Although Europe has well-established surveillance infrastructures, substantial heterogeneity persists among countries with respect to microbiological and genomic diagnostic capacity, reporting practices, infection prevention and control (IPC), antimicrobial stewardship, healthcare infrastructure, and implementation of national policies. These differences limit data comparability and may delay the detection of colonization, outbreaks, and cross-border transmission. The available evidence indicates that effective CRE control requires integrated surveillance combining microbiological, genomic, epidemiological, and antimicrobial consumption data within a coordinated One Health framework. Further expansion of genomic surveillance, harmonization of surveillance indicators, strengthening of healthcare system preparedness, and wider implementation of antimicrobial stewardship programmes are identified as priority areas for improve CRE prevention and control across Europe. By integrating evidence across surveillance, diagnostics, infection prevention and control, and antimicrobial stewardship, this review highlights key gaps in current European approaches and provides a framework for prioritizing future surveillance and preparedness efforts.<\/jats:p>","DOI":"10.3390\/antibiotics15080790","type":"journal-article","created":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T12:01:26Z","timestamp":1786968086000},"page":"790","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Carbapenem-Resistant Enterobacterales (CRE) in Europe: Surveillance Challenges, Emerging Threats and Public Health Preparedness"],"prefix":"10.3390","volume":"15","author":[{"ORCID":"https:\/\/orcid.org\/0009-0001-8442-0007","authenticated-orcid":false,"given":"Katarzyna","family":"Kuszewska","sequence":"first","affiliation":[{"name":"Diagnostic Laboratory, St. Alexander Hospital, 25-316 Kielce, Poland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2756-3340","authenticated-orcid":false,"given":"Karolina","family":"Klesiewicz","sequence":"additional","affiliation":[{"name":"Department of Pharmaceutical Microbiology, Faculty of Pharmacy, Jagiellonian University Medical College, 30-688 Krakow, Poland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5404-0388","authenticated-orcid":false,"given":"Paulina","family":"Le\u015bniak","sequence":"additional","affiliation":[{"name":"Department of Pharmaceutical Microbiology, Faculty of Pharmacy, Jagiellonian University Medical College, 30-688 Krakow, Poland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0814-8638","authenticated-orcid":false,"given":"Agnieszka","family":"Chmielarczyk","sequence":"additional","affiliation":[{"name":"Department of Microbiology, Faculty of Medicine, Jagiellonian University Medical College, 31-121 Krakow, Poland"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2026,8,15]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"4363","DOI":"10.2147\/IDR.S337611","article-title":"Emerging Carbapenem-Resistant Enterobacteriaceae Infection, Its Epidemiology and Novel Treatment Options: A Review","volume":"14","author":"Tilahun","year":"2021","journal-title":"Infect. Drug Resist."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"2706","DOI":"10.1111\/1541-4337.13159","article-title":"Dissemination of carbapenemase-producing Enterobacteriaceae and associated resistance determinants through global food systems","volume":"22","author":"Smith","year":"2023","journal-title":"Compr. Rev. Food Sci. Food Saf."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"2312","DOI":"10.2174\/1381612828666220608120238","article-title":"Antibiotics and Antibiotic Resistance- Flipsides of the Same Coin","volume":"28","author":"Bhardwaj","year":"2022","journal-title":"Curr. Pharm. Des."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"837","DOI":"10.1016\/j.chom.2024.05.015","article-title":"Antibiotic resistance: A key microbial survival mechanism that threatens public health","volume":"32","author":"Abbas","year":"2024","journal-title":"Cell Host Microbe"},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"16333","DOI":"10.1038\/s41598-024-64992-8","article-title":"Carbapenem-resistant Enterobacteriaceae in the livestock, humans and environmental samples around the globe: A systematic review and meta-analysis","volume":"14","author":"Tuhamize","year":"2024","journal-title":"Sci. Rep."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"e24655","DOI":"10.1002\/jcla.24655","article-title":"Antibiotic resistance: The challenges and some emerging strategies for tackling a global menace","volume":"36","author":"Ugwu","year":"2022","journal-title":"J. Clin. Lab. Anal."},{"key":"ref_7","first-page":"134","article-title":"Epidemiological Characteristics of Carbapenemase Producing Carbapenem-Resistant Enterobacteriaceae Colonization","volume":"16","author":"Jeong","year":"2022","journal-title":"Asian Nurs. Res. (Korean Soc. Nurs. Sci.)"},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1097\/QCO.0000000000000622","article-title":"Carbapenem use in critically ill patients","volume":"33","author":"Patrier","year":"2020","journal-title":"Curr. Opin. Infect. Dis."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"4943","DOI":"10.1128\/AAC.00296-11","article-title":"Carbapenems: Past, present, and future","volume":"55","author":"Endimiani","year":"2011","journal-title":"Antimicrob. Agents Chemother."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/j.ejim.2022.01.029","article-title":"Optimizing antibiotic therapies to reduce the risk of bacterial resistance","volume":"99","author":"Bassetti","year":"2022","journal-title":"Eur. J. Intern. Med."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1038\/s41533-021-00229-9","article-title":"Does diagnostic uncertainty increase antibiotic prescribing in primary care?","volume":"31","author":"Wang","year":"2021","journal-title":"npj Prim. Care Respir. Med."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1186\/s40560-020-0429-6","article-title":"Molecular diversity of extended-spectrum \u03b2-lactamases and carbapenemases, and antimicrobial resistance","volume":"8","author":"Sawa","year":"2020","journal-title":"J. Intensive Care"},{"key":"ref_13","doi-asserted-by":"crossref","unstructured":"Caliskan-Aydogan, O., and Alocilja, E.C. (2023). A Review of Carbapenem Resistance in Enterobacterales and Its Detection Techniques. Microorganisms, 11.","DOI":"10.3390\/microorganisms11061491"},{"key":"ref_14","doi-asserted-by":"crossref","unstructured":"Noster, J., Thelen, P., and Hamprecht, A. (2021). Detection of Multidrug-Resistant Enterobacterales-From ESBLs to Carbapenemases. Antibiotics, 10.","DOI":"10.3390\/antibiotics10091140"},{"key":"ref_15","doi-asserted-by":"crossref","unstructured":"Hammoudi Halat, D., and Ayoub Moubareck, C. (2020). The Current Burden of Carbapenemases: Review of Significant Properties and Dissemination among Gram-Negative Bacteria. Antibiotics, 9.","DOI":"10.3390\/antibiotics9040186"},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"564","DOI":"10.1097\/QCO.0000000000000966","article-title":"MDR\/XDR\/PDR or DTR? Which definition best fits the resistance profile of Pseudomonas aeruginosa?","volume":"36","author":"Cosentino","year":"2023","journal-title":"Curr. Opin. Infect. Dis."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"4653","DOI":"10.2147\/IDR.S283488","article-title":"Multidrug-Resistant and Extensively Drug-Resistant Enterobacteriaceae: Prevalence, Treatments, and Outcomes\u2014A Retrospective Cohort Study","volume":"13","author":"Alkofide","year":"2020","journal-title":"Infect. Drug Resist."},{"key":"ref_18","unstructured":"World Health Organization (2024). Bacterial Priority Pathogens List, WHO."},{"key":"ref_19","doi-asserted-by":"crossref","unstructured":"Xu, W., Shang, L., Li, X., Yu, J., Shen, J., Li, Y., He, Q., Chen, L., Wang, D., and Wei, Y. (2026). Current progress in antibacterial agents for carbapenem-resistant enterobacterales. Front. Pharmacol., 17.","DOI":"10.3389\/fphar.2026.1796557"},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"107553","DOI":"10.1016\/j.ijantimicag.2025.107553","article-title":"Susceptibility to new antibiotics and genetic characterisation of carbapenemase-producing Enterobacterales: Low activity of cefiderocol against NDM-producing isolates","volume":"66","author":"Chatzopoulou","year":"2025","journal-title":"Int. J. Antimicrob. Agents"},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"2423","DOI":"10.1007\/s40121-024-01044-8","article-title":"Navigating the Current Treatment Landscape of Metallo-\u03b2-Lactamase-Producing Gram-Negative Infections: What are the Limitations?","volume":"13","author":"Grabein","year":"2024","journal-title":"Infect. Dis. Ther."},{"key":"ref_22","doi-asserted-by":"crossref","unstructured":"Marino, A., Maniaci, A., Lentini, M., Ronsivalle, S., Nunnari, G., Cocuzza, S., Parisi, F.M., Cacopardo, B., Lavalle, S., and La Via, L. (2025). The Global Burden of Multidrug-Resistant Bacteria. Epidemiologia, 6.","DOI":"10.3390\/epidemiologia6020021"},{"key":"ref_23","doi-asserted-by":"crossref","unstructured":"Birlutiu, V., and Birlutiu, R.-M. (2025). An Overview of the Epidemiology of Multidrug Resistance and Bacterial Resistance Mechanisms: What Solutions Are Available? A Comprehensive Review. Microorganisms, 13.","DOI":"10.3390\/microorganisms13092194"},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"1290","DOI":"10.1093\/cid\/cix893","article-title":"Carbapenemase-Producing Organisms: A Global Scourge","volume":"66","author":"Bonomo","year":"2018","journal-title":"Clin. Infect. Dis."},{"key":"ref_25","doi-asserted-by":"crossref","unstructured":"Alvisi, G., Curtoni, A., Fonnesu, R., Piazza, A., Signoretto, C., Piccinini, G., Sassera, D., and Gaibani, P. (2025). Epidemiology and Genetic Traits of Carbapenemase-Producing Enterobacterales: A Global Threat to Human Health. Antibiotics, 14.","DOI":"10.3390\/antibiotics14020141"},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1128\/AAC.38.1.71","article-title":"Molecular characterization of an enterobacterial metallo beta-lactamase found in a clinical isolate of Serratia marcescens that shows imipenem resistance","volume":"38","author":"Osano","year":"1994","journal-title":"Antimicrob. Agents Chemother."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"1151","DOI":"10.1128\/AAC.45.4.1151-1161.2001","article-title":"Novel carbapenem-hydrolyzing beta-lactamase, KPC-1, from a carbapenem-resistant strain of Klebsiella pneumoniae","volume":"45","author":"Yigit","year":"2001","journal-title":"Antimicrob. Agents Chemother."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"544","DOI":"10.1186\/s12982-025-00929-4","article-title":"Carbapenem resistant enterobacterales: A covert menace in low and middle income countries","volume":"22","author":"Otaigbe","year":"2025","journal-title":"Discov. Public Health"},{"key":"ref_29","unstructured":"Organisation for Economic Co-operation and Development (2023). Health Inequality and Universal Health Coverage, OECD."},{"key":"ref_30","doi-asserted-by":"crossref","unstructured":"Mackenbach, J.P. (2019). Health Inequalities: Persistence and Change in European Welfare States, Oxford University Press.","DOI":"10.1093\/oso\/9780198831419.001.0001"},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"1235","DOI":"10.1016\/S0140-6736(12)62086-8","article-title":"Migration and health in an increasingly diverse Europe","volume":"381","author":"Rechel","year":"2013","journal-title":"Lancet"},{"key":"ref_32","unstructured":"European Centre for Disease Prevention and Control (2023). EU Laboratory Capability Monitoring System (EULabCap): Report on 2021 Survey of EU\/EEA Country Capabilities and Capacities."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1186\/s13756-022-01165-0","article-title":"Infection prevention and control policies in hospitals and prevalence of highly resistant microorganisms: An international comparative study","volume":"11","author":"Alp","year":"2022","journal-title":"Antimicrob. Resist. Infect. Control"},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1186\/s13690-024-01427-w","article-title":"Community antibiotic consumption in the European Union\/European economic area: Late-pandemic rebound and seasonality analysis","volume":"82","author":"Vermeulen","year":"2024","journal-title":"Arch. Public Health"},{"key":"ref_35","unstructured":"European Centre for Disease Prevention and Control (2025). Carbapenem-Resistant Enterobacterales, Third Update."},{"key":"ref_36","unstructured":"European Centre for Disease Prevention and Control (2026, June 14). European Antimicrobial Resistance Surveillance Network (EARS-Net). Available online: https:\/\/www.ecdc.europa.eu\/en\/about-us\/partnerships-and-networks\/disease-and-laboratory-networks\/ears-net."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1016\/S1473-3099(18)30605-4","article-title":"Attributable deaths and disability-adjusted life-years caused by infections with antibiotic-resistant bacteria in the EU and the European Economic Area in 2015: A population-level modelling analysis","volume":"19","author":"Cassini","year":"2019","journal-title":"Lancet Infect. Dis."},{"key":"ref_38","unstructured":"European Centre for Disease Prevention and Control (2025). Antimicrobial Resistance in the EU\/EEA (EARS-Net)\u2014Annual Epidemiological Report for 2024."},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"5575","DOI":"10.1099\/ijsem.0.001485","article-title":"Genome-based phylogeny and taxonomy of the \u201cEnterobacteriales\u201d: Proposal for Enterobacterales ord. nov. divided into the families Enterobacteriaceae, Erwiniaceae fam. nov., Pectobacteriaceae fam. nov., Yersiniaceae fam. nov., Hafniaceae fam. nov., Morganellaceae fam. nov., and Budviciaceae fam. nov","volume":"66","author":"Adeolu","year":"2016","journal-title":"Int. J. Syst. Evol. Microbiol."},{"key":"ref_40","unstructured":"WHO Regional Office for Europe and European Centre for Disease Prevention and Control (2025). Surveillance of Antimicrobial Resistance in Europe, 2024 Data: Executive Summary, WHO Regional Office for Europe. Available online: https:\/\/www.ecdc.europa.eu\/sites\/default\/files\/documents\/antimicrobial-resistance-surveillance-Europe-2024-data.pdf."},{"key":"ref_41","unstructured":"European Centre for Disease Prevention and Control (2024). Country Profiles 2023\u20132024."},{"key":"ref_42","unstructured":"World Health Organization (2025). Global Antimicrobial Resistance and Use Surveillance System (GLASS) Report 2025, World Health Organization."},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1038\/s42003-023-05745-7","article-title":"Carbapenem-resistant Escherichia coli exhibit diverse spatiotemporal epidemiological characteristics across the globe","volume":"7","author":"Huang","year":"2024","journal-title":"Commun. Biol."},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"e122990","DOI":"10.5812\/jjm-122990","article-title":"Prevalence and Antimicrobial Resistance of Bloodstream Infections Caused by ESKAPEEc Pathogens: A Five-Year Analysis","volume":"15","author":"Yardimci","year":"2022","journal-title":"Jundishapur J. Microbiol."},{"key":"ref_45","doi-asserted-by":"crossref","unstructured":"Marino, A., Campanella, E., Stracquadanio, S., Calvo, M., Migliorisi, G., Nicolosi, A., Cosentino, F., Marletta, S., Spampinato, S., and Prestifilippo, P. (2023). Ceftazidime\/Avibactam and Meropenem\/Vaborbactam for the Management of Enterobacterales Infections: A Narrative Review, Clinical Considerations, and Expert Opinion. Antibiotics, 12.","DOI":"10.3390\/antibiotics12101521"},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"115945","DOI":"10.1016\/j.diagmicrobio.2023.115945","article-title":"Ceftazidime-avibactam, meropenem-vaborbactam, and imipenem-relebactam activities against multidrug-resistant Enterobacterales from United States Medical Centers (2018\u20132022)","volume":"106","author":"Sader","year":"2023","journal-title":"Diagn. Microbiol. Infect. Dis."},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1177\/8755122520934726","article-title":"Review of Ceftazidime-Avibactam, Meropenem-Vaborbactam, and Imipenem\/Cilastatin-Relebactam to Target Klebsiella pneumoniae Carbapenemase-Producing Enterobacterales","volume":"36","author":"Hayden","year":"2020","journal-title":"J. Pharm. Technol."},{"key":"ref_48","unstructured":"European Centre for Disease Prevention and Control (2026, July 19). European Antimicrobial Resistance Genes Surveillance Network (EURGen-Net). Available online: https:\/\/www.ecdc.europa.eu\/en\/about-us\/who-we-work\/disease-and-laboratory-networks\/EURGen-net."},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"2000627","DOI":"10.2807\/1560-7917.ES.2020.25.20.2000627","article-title":"Cross-border spread of blaNDM-1- and blaOXA-48-positive Klebsiella pneumoniae: A European collaborative analysis of whole genome sequencing and epidemiological data, 2014 to 2019","volume":"25","author":"Ludden","year":"2020","journal-title":"Euro Surveill."},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"2300209","DOI":"10.2807\/1560-7917.ES.2023.28.19.2300209","article-title":"Rapid cross-border emergence of NDM-5-producing Escherichia coli in the European Union\/European Economic Area, 2012 to June 2022","volume":"28","author":"Linkevicius","year":"2023","journal-title":"Euro Surveill."},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"2500439","DOI":"10.2807\/1560-7917.ES.2025.30.27.2500439","article-title":"Cross-border spread of a mosaic resistance (OXA-48) and virulence (aerobactin) plasmid in Klebsiella pneumoniae: A European Antimicrobial Resistance Genes Surveillance Network investigation, Europe, February 2019 to October 2024","volume":"30","author":"Linkevicius","year":"2025","journal-title":"Eurosurveillance"},{"key":"ref_52","unstructured":"European Centre for Disease Prevention and Control (2026, July 19). Healthcare-Associated Infections Surveillance Network (HAI-Net). Available online: https:\/\/www.ecdc.europa.eu\/en\/about-us\/partnerships-and-networks\/disease-and-laboratory-networks\/hai-net."},{"key":"ref_53","doi-asserted-by":"crossref","unstructured":"Szab\u00f3, S., Feier, B., Capatina, D., Tertis, M., Cristea, C., and Popa, A. (2022). An Overview of Healthcare Associated Infections and Their Detection Methods Caused by Pathogen Bacteria in Romania and Europe. J. Clin. Med., 11.","DOI":"10.3390\/jcm11113204"},{"key":"ref_54","unstructured":"European Centre for Disease Prevention and Control (2025). Antimicrobial Consumption in the EU\/EEA (ESAC-Net)\u2014Annual Epidemiological Report 2024, ECDC."},{"key":"ref_55","unstructured":"WHO Collaborating Centre for Drug Statistics Methodology (2025). Defined Daily Dose (DDD): Definition and General Considerations, World Health Organization."},{"key":"ref_56","unstructured":"European Centre for Disease Prevention and Control (2024). Point Prevalence Survey of Healthcare-Associated Infections and Antimicrobial Use in European Acute Care Hospitals 2022\u20132023."},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1080\/20477724.2019.1632070","article-title":"Point prevalence surveys of health-care-associated infections: A systematic review","volume":"113","author":"Saleem","year":"2019","journal-title":"Pathog. Glob. Health"},{"key":"ref_58","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1186\/s13756-025-01648-w","article-title":"Dutch guideline for the prevention and control of multidrug-resistant organisms in the hospital setting, 2024 update","volume":"14","author":"Sussenbach","year":"2025","journal-title":"Antimicrob. Resist. Infect. Control"},{"key":"ref_59","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1186\/s13756-025-01552-3","article-title":"Antimicrobial resistance in the Nordics: Mapping existing surveillance systems and assessing the impact of COVID-19 using regression models","volume":"14","author":"Tran","year":"2025","journal-title":"Antimicrob. Resist. Infect. Control"},{"key":"ref_60","unstructured":"European Centre for Disease Prevention and Control (2025). Surveillance of Antimicrobial Resistance in Europe, 2024 Data."},{"key":"ref_61","unstructured":"European Society of Clinical Microbiology and Infectious Diseases (2023). ESCMID Strategic Plan 2023\u20132028, European Society of Clinical Microbiology and Infectious Diseases."},{"key":"ref_62","unstructured":"European Committee on Antimicrobial Susceptibility Testing (2024). EUCAST: Rationale, Mandate and Structure, European Committee on Antimicrobial Susceptibility Testing."},{"key":"ref_63","unstructured":"ESCMID Guidelines Development Group (2022). ESCMID methodology for the development of clinical guidelines. Clin. Microbiol. Infect., 28, 1221\u20131230."},{"key":"ref_64","unstructured":"European Committee on Antimicrobial Susceptibility Testing (2026, July 19). EUCAST Official Website. Available online: https:\/\/www.eucast.org."},{"key":"ref_65","unstructured":"European Committee on Antimicrobial Susceptibility Testing (EUCAST) (2026). EUCAST Clinical Breakpoint Tables for Interpretation of MICs and Zone Diameters, Version 16.0, European Committee on Antimicrobial Susceptibility Testing (EUCAST)."},{"key":"ref_66","unstructured":"World Health Organization (2026, July 19). Central Asian and European Surveillance of Antimicrobial Resistance (CAESAR). Available online: https:\/\/www.who.int\/europe\/groups\/central-asian-and-european-surveillance-of-antimicrobial-resistance-(caesar)."},{"key":"ref_67","unstructured":"UK Health Security Agency (2026, July 19). UK Health Security Agency, Available online: https:\/\/www.gov.uk\/government\/organisations\/uk-health-security-agency."},{"key":"ref_68","unstructured":"European Committee on Antimicrobial Susceptibility Testing (EUCAST) (2026, May 01). National AST Committees (NAC). Available online: https:\/\/www.eucast.org\/about-eucast\/organisation\/national-ast-committees-nac\/."},{"key":"ref_69","unstructured":"European Centre for Disease Prevention and Control (2025). Analysis Plan for the Survey of Carbapenem-Resistant Enterobacterales 2025 (CRE25 Survey)."},{"key":"ref_70","unstructured":"European Centre for Disease Prevention and Control, and World Health Organization Regional Office for Europe (2024). Surveillance of Antimicrobial Resistance in Europe, 2023 Data: Executive Summary."},{"key":"ref_71","unstructured":"World Health Organization (2019). Antimicrobial Stewardship Programmes in Health-Care Facilities in Low- and Middle-Income Countries: A WHO Practical Toolkit, World Health Organization."},{"key":"ref_72","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1177\/17571774211066762","article-title":"Infection prevention and control strategies against carbapenem resistant Enterobacteriaceae\u2014A systematic review","volume":"23","author":"Ferreira","year":"2022","journal-title":"J. Infect. Prev."},{"key":"ref_73","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1186\/s13756-017-0259-z","article-title":"Infection prevention and control measures and tools for the prevention of entry of carbapenem-resistant Enterobacteriaceae into healthcare settings: Guidance from the European Centre for Disease Prevention and Control","volume":"6","author":"Magiorakos","year":"2017","journal-title":"Antimicrob. Resist. Infect. Control"},{"key":"ref_74","unstructured":"World Health Organization (2026, June 14). Infection Prevention and Control. Available online: https:\/\/www.who.int\/teams\/integrated-health-services\/infection-prevention-control."},{"key":"ref_75","doi-asserted-by":"crossref","first-page":"e466","DOI":"10.1016\/S2214-109X(23)00019-0","article-title":"An analysis of existing national action plans for antimicrobial resistance\u2014Gaps and opportunities in strategies optimising antibiotic use in human populations","volume":"11","author":"Charani","year":"2023","journal-title":"Lancet Glob. Health"},{"key":"ref_76","unstructured":"European Centre for Disease Prevention and Control (2026, July 19). Antimicrobial Consumption (AMC2) Dashboard. Available online: https:\/\/qap.ecdc.europa.eu\/public\/extensions\/AMC2_Dashboard\/AMC2_Dashboard.html#eu-consumption-tab."},{"key":"ref_77","unstructured":"World Health Organization (2024). Global Report on Infection Prevention and Control 2024, World Health Organization."},{"key":"ref_78","doi-asserted-by":"crossref","first-page":"e2406017","DOI":"10.4014\/jmb.2406.06017","article-title":"Gut Microbiome-Based Strategies for the Control of Carbapenem-Resistant Enterobacteriaceae","volume":"35","author":"Lee","year":"2025","journal-title":"J. Microbiol. Biotechnol."},{"key":"ref_79","doi-asserted-by":"crossref","first-page":"107335","DOI":"10.1016\/j.ijantimicag.2024.107335","article-title":"Epidemiology of subsequent carbapenem-resistant enterobacterales (CRE) infection among rectal carriers: A meta-analysis of incidence, risk factors and their association with geographic region and age","volume":"64","author":"Wei","year":"2024","journal-title":"Int. J. Antimicrob. Agents"},{"key":"ref_80","doi-asserted-by":"crossref","unstructured":"Kim, Y.K., Chang, I.B., Kim, H.S., Song, W., and Lee, S.S. (2021). Prolonged Carriage of Carbapenemase-Producing Enterobacteriaceae: Clinical Risk Factors and the Influence of Carbapenemase and Organism Types. J. Clin. Med., 10.","DOI":"10.3390\/jcm10020310"},{"key":"ref_81","doi-asserted-by":"crossref","first-page":"26017","DOI":"10.1038\/s41598-024-76261-9","article-title":"Correlation between intestinal CRE colonization and consequent systemic infection in hospitalized patients in China","volume":"14","author":"Xiao","year":"2024","journal-title":"Sci. Rep."},{"key":"ref_82","unstructured":"European Centre for Disease Prevention and Control (2026). Proposal for EU Guidance on the Establishment and Implementation of Infection Prevention and Control Programmes in Healthcare."},{"key":"ref_83","doi-asserted-by":"crossref","unstructured":"Chen, H.-Y., Jean, S.-S., Lee, Y.-L., Lu, M.-C., Ko, W.-C., Liu, P.-Y., and Hsueh, P.-R. (2021). Carbapenem-Resistant Enterobacterales in Long-Term Care Facilities: A Global and Narrative Review. Front. Cell Infect. Microbiol., 11.","DOI":"10.3389\/fcimb.2021.601968"},{"key":"ref_84","unstructured":"European Centre for Disease Prevention and Control (2025). Protocol for Genomic Surveillance of Carbapenem-Resistant Enterobacterales 2025 (CRE25 Survey)."},{"key":"ref_85","doi-asserted-by":"crossref","unstructured":"Struelens, M.J., Ludden, C., Werner, G., Sintchenko, V., Jokelainen, P., and Ip, M. (2024). Real-time genomic surveillance for enhanced control of infectious diseases and antimicrobial resistance. Front. Sci., 2.","DOI":"10.3389\/fsci.2024.1298248"},{"key":"ref_86","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1080\/21505594.2016.1255381","article-title":"Screening for carbapenem-resistant Enterobacteriaceae: Who, When, and How?","volume":"8","author":"Richter","year":"2017","journal-title":"Virulence"},{"key":"ref_87","doi-asserted-by":"crossref","first-page":"e123","DOI":"10.1017\/ash.2025.173","article-title":"Prioritizing isolation precautions: A patient-centered approach to infection prevention and control","volume":"5","author":"Carrara","year":"2025","journal-title":"Antimicrob. Steward. Healthc. Epidemiol."},{"key":"ref_88","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1177\/1757177420907696","article-title":"A systematic review and meta-synthesis of policy intervention characteristics that influence the implementation of government-directed policy in the hospital setting: Implications for infection prevention and control","volume":"21","author":"Havers","year":"2020","journal-title":"J. Infect. Prev."},{"key":"ref_89","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1186\/s13756-022-01097-9","article-title":"Infectious Diseases Surveillance Information System-Antimicrobial Resistance (ISIS-AR) Study Group; Dutch CPE Surveillance Study Group. Epidemiology of carbapenem-resistant and carbapenemase-producing Enterobacterales in the Netherlands 2017\u20132019","volume":"11","author":"Wielders","year":"2022","journal-title":"Antimicrob. Resist. Infect. Control"},{"key":"ref_90","unstructured":"World Health Organization (2023). WHO AWaRe (Access, Watch, Reserve) Classification of Antibiotics for Evaluation and Monitoring of Use, 2023, World Health Organization."},{"key":"ref_91","unstructured":"Council of the European Union (2023). Council Recommendation of 13 June 2023 on stepping up EU actions to combat antimicrobial resistance in a One Health approach (2023\/C 220\/01). Off. J. Eur. Union, C 220, 1\u201320. Available online: https:\/\/eur-lex.europa.eu\/legal-content\/EN\/TXT\/?uri=CELEX:32023H0622(01)."},{"key":"ref_92","first-page":"S67","article-title":"Infectious Diseases Society of America 2024 Guidance on the Treatment of Antimicrobial-Resistant Gram-Negative Infections","volume":"79","author":"Tamma","year":"2024","journal-title":"Clin. Infect. Dis."},{"key":"ref_93","unstructured":"World Health Organization (2017). Guidelines for the Prevention and Control of Carbapenem-Resistant Enterobacteriaceae, Acinetobacter Baumannii and Pseudomonas Aeruginosa in Health Care Facilities, World Health Organization."},{"key":"ref_94","unstructured":"European Centre for Disease Prevention and Control (2024). Emergence of Hypervirulent Klebsiella Pneumoniae ST23 Carrying Carbapenemase Genes in EU\/EEA Countries, First Update."},{"key":"ref_95","doi-asserted-by":"crossref","first-page":"5092","DOI":"10.1038\/s41467-024-49349-z","article-title":"International and regional spread of carbapenem-resistant Klebsiella pneumoniae in Europe","volume":"15","author":"Kostyanev","year":"2024","journal-title":"Nat. Commun."},{"key":"ref_96","doi-asserted-by":"crossref","first-page":"101320","DOI":"10.1016\/j.lanmic.2025.101321","article-title":"Persistent spread of carbapenemase-producing Klebsiella pneumoniae in acute care hospitals in 36 European countries (the CCRE survey): A prospective, multicentre, cross-sectional, epidemiological, microbiological, and genomic surveillance study","volume":"7","author":"David","year":"2026","journal-title":"Lancet Microbe"},{"key":"ref_97","doi-asserted-by":"crossref","first-page":"4188","DOI":"10.1038\/s41467-021-24448-3","article-title":"A genomic surveillance framework and genotyping tool for Klebsiella pneumoniae and its related species complex","volume":"12","author":"Lam","year":"2021","journal-title":"Nat. Commun."},{"key":"ref_98","doi-asserted-by":"crossref","first-page":"1919","DOI":"10.1038\/s41564-019-0492-8","article-title":"Epidemic of carbapenem-resistant Klebsiella pneumoniae in Europe is driven by nosocomial spread","volume":"4","author":"David","year":"2019","journal-title":"Nat. Microbiol."},{"key":"ref_99","doi-asserted-by":"crossref","unstructured":"Bonnin, R.A., Jousset, A.B., Emeraud, C., Oueslati, S., Dortet, L., and Naas, T. (2021). Genetic Diversity, Biochemical Properties, and Detection Methods of Minor Carbapenemases in Enterobacterales. Front. Med., 8.","DOI":"10.3389\/fmed.2020.616490"},{"key":"ref_100","doi-asserted-by":"crossref","first-page":"668","DOI":"10.15585\/mmwr.mm6723a4","article-title":"Notes from the Field: Carbapenemase-Producing Carbapenem-Resistant Enterobacteriaceae from Less Common Enterobacteriaceae Genera\u2014United States, 2014\u20132017","volume":"67","author":"Walters","year":"2018","journal-title":"MMWR Morb. Mortal. Wkly. Rep."},{"key":"ref_101","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1016\/j.drup.2016.09.002","article-title":"The rapid spread of carbapenem-resistant Enterobacteriaceae","volume":"29","author":"Potter","year":"2016","journal-title":"Drug Resist. Updat."},{"key":"ref_102","doi-asserted-by":"crossref","first-page":"127249","DOI":"10.1016\/j.micres.2022.127249","article-title":"Global spread of carbapenem-resistant Enterobacteriaceae: Epidemiological features, resistance mechanisms, detection and therapy","volume":"266","author":"Ma","year":"2023","journal-title":"Microbiol. Res."},{"key":"ref_103","doi-asserted-by":"crossref","unstructured":"Gonz\u00e1lez, L.V. (2022). Human Pathogenic Enterobacterales. Encyclopedia of Infection and Immunity, Elsevier.","DOI":"10.1016\/B978-0-12-818731-9.00160-9"},{"key":"ref_104","doi-asserted-by":"crossref","unstructured":"De Angelis, G., Del Giacomo, P., Posteraro, B., Sanguinetti, M., and Tumbarello, M. (2020). Molecular Mechanisms, Epidemiology, and Clinical Importance of \u03b2-Lactam Resistance in Enterobacteriaceae. Int. J. Mol. Sci., 21.","DOI":"10.3390\/ijms21145090"},{"key":"ref_105","doi-asserted-by":"crossref","unstructured":"Pospi\u0161il, M., Car, H., Elve\u0111i-Ga\u0161parovi\u0107, V., Beader, N., Herljevi\u0107, Z., and Bedeni\u0107, B. (2023). Bloodstream Infections by AmpC-Producing Enterobacterales: Risk Factors and Therapeutic Outcome. Pathogens, 12.","DOI":"10.3390\/pathogens12091125"},{"key":"ref_106","doi-asserted-by":"crossref","first-page":"965","DOI":"10.2147\/IDR.S199844","article-title":"Molecular mechanisms related to colistin resistance in Enterobacteriaceae","volume":"12","author":"Aghapour","year":"2019","journal-title":"Infect. Drug Resist."},{"key":"ref_107","doi-asserted-by":"crossref","unstructured":"Gogry, F.A., Siddiqui, M.T., Sultan, I., and Haq, Q.M.R. (2021). Current Update on Intrinsic and Acquired Colistin Resistance Mechanisms in Bacteria. Front. Med., 8.","DOI":"10.3389\/fmed.2021.677720"},{"key":"ref_108","doi-asserted-by":"crossref","unstructured":"Yap, P.S.-X., Cheng, W.-H., Chang, S.-K., Lim, S.-H.E., and Lai, K.-S. (2022). MgrB Mutations and Altered Cell Permeability in Colistin Resistance in Klebsiella pneumoniae. Cells, 11.","DOI":"10.3390\/cells11192995"},{"key":"ref_109","doi-asserted-by":"crossref","first-page":"ofv050","DOI":"10.1093\/ofid\/ofv050","article-title":"Treatment Options for Carbapenem-Resistant Enterobacteriaceae Infections","volume":"2","author":"Morrill","year":"2015","journal-title":"Open Forum Infect. Dis."},{"key":"ref_110","doi-asserted-by":"crossref","first-page":"e0021622","DOI":"10.1128\/aac.00216-22","article-title":"OXA-48-Like \u03b2-Lactamases: Global Epidemiology, Treatment Options, and Development Pipeline","volume":"66","author":"Boyd","year":"2022","journal-title":"Antimicrob. Agents Chemother."},{"key":"ref_111","doi-asserted-by":"crossref","unstructured":"Rivera-Izquierdo, M., L\u00e1inez-Ramos-Bossini, A.J., Rivera-Izquierdo, C., L\u00f3pez-G\u00f3mez, J., Fern\u00e1ndez-Mart\u00ednez, N.F., Redruello-Guerrero, P., Mart\u00edn-Delosreyes, L.M., Mart\u00ednez-Ruiz, V., Moreno-Rold\u00e1n, E., and Jim\u00e9nez-Mej\u00edas, E. (2021). OXA-48 Carbapenemase-Producing Enterobacterales in Spanish Hospitals: An Updated Comprehensive Review on a Rising Antimicrobial Resistance. Antibiotics, 10.","DOI":"10.3390\/antibiotics10010089"},{"key":"ref_112","doi-asserted-by":"crossref","first-page":"2553","DOI":"10.1093\/cid\/ciz1130","article-title":"A Multispecies Cluster of GES-5 Carbapenemase\u2013Producing Enterobacterales Linked by a Geographically Disseminated Plasmid","volume":"71","author":"Ellington","year":"2020","journal-title":"Clin. Infect. Dis."},{"key":"ref_113","doi-asserted-by":"crossref","first-page":"106694","DOI":"10.1016\/j.mimet.2023.106694","article-title":"Are GES carbapenemases underdiagnosed? An allelic discrimination assay for their accurate detection and differentiation","volume":"207","author":"Siller","year":"2023","journal-title":"J. Microbiol. Methods"},{"key":"ref_114","doi-asserted-by":"crossref","first-page":"2795","DOI":"10.1093\/jac\/dkab267","article-title":"Pitfalls in genotypic antimicrobial susceptibility testing caused by low expression of bla KPC in Escherichia coli","volume":"76","author":"Kocer","year":"2021","journal-title":"J. Antimicrob. Chemother."},{"key":"ref_115","doi-asserted-by":"crossref","first-page":"e00054-22","DOI":"10.1128\/cmr.00054-22","article-title":"Laboratory detection of carbapenemases among Gram-negative organisms","volume":"37","author":"Simner","year":"2024","journal-title":"Clin. Microbiol. Rev."},{"key":"ref_116","doi-asserted-by":"crossref","first-page":"4753","DOI":"10.1128\/AAC.00334-12","article-title":"Role of ISKpn7 and deletions in blaKPC gene expression","volume":"56","author":"Naas","year":"2012","journal-title":"Antimicrob. Agents Chemother."},{"key":"ref_117","doi-asserted-by":"crossref","first-page":"2147","DOI":"10.1128\/AAC.02411-12","article-title":"Characterization of porin expression in Klebsiella pneumoniae Carbapenemase (KPC)-producing K. pneumoniae identifies isolates most susceptible to the combination of colistin and carbapenems","volume":"57","author":"Hong","year":"2013","journal-title":"Antimicrob. Agents Chemother."},{"key":"ref_118","doi-asserted-by":"crossref","unstructured":"Al-Rujaibi, A., Al-Jabri, Z., Al-Jardani, A., Al-Rashdi, A., Al-Mamari, A., Al-Sumri, S., Sami, H., Al Muharrmi, Z., and Rizvi, M. (2025). Assessment of Phenotypic Tools for Detection of OXA-48, KPC, and NDM in Klebsiella pneumoniae in Oman. Diagnostics, 15.","DOI":"10.20944\/preprints202501.1641.v1"},{"key":"ref_119","unstructured":"European Centre for Disease Prevention and Control (2011). Risk Assessment on the Spread of Carbapenemase-Producing Enterobacteriaceae (CPE) Through Patient Transfer Between Healthcare Facilities, with Special Emphasis on Cross-Border Transfer."},{"key":"ref_120","doi-asserted-by":"crossref","unstructured":"Tang, M., Kong, X., Hao, J., and Liu, J. (2020). Epidemiological Characteristics and Formation Mechanisms of Multidrug-Resistant Hypervirulent Klebsiella pneumoniae. Front. Microbiol., 11.","DOI":"10.3389\/fmicb.2020.581543"},{"key":"ref_121","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1186\/s13073-024-01332-5","article-title":"The emergence of highly resistant and hypervirulent Klebsiella pneumoniae CC14 clone in a tertiary hospital over 8 years","volume":"16","author":"Hala","year":"2024","journal-title":"Genome Med."},{"key":"ref_122","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1080\/14787210.2024.2305854","article-title":"Carbapenem-resistant Klebsiella pneumoniae: The role of plasmids in emergence, dissemination, and evolution of a major clinical challenge","volume":"22","author":"Pollini","year":"2024","journal-title":"Expert. Rev. Anti Infect. Ther."},{"key":"ref_123","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1128\/CMR.00116-14","article-title":"The Role of Epidemic Resistance Plasmids and International High-Risk Clones in the Spread of Multidrug-Resistant Enterobacteriaceae","volume":"28","author":"Mathers","year":"2015","journal-title":"Clin. Microbiol. Rev."},{"key":"ref_124","doi-asserted-by":"crossref","first-page":"e00088-17","DOI":"10.1128\/CMR.00088-17","article-title":"Mobile Genetic Elements Associated with Antimicrobial Resistance","volume":"31","author":"Partridge","year":"2018","journal-title":"Clin. Microbiol. Rev."},{"key":"ref_125","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1186\/s13073-019-0706-y","article-title":"Genomic surveillance for hypervirulence and multi-drug resistance in invasive Klebsiella pneumoniae from South and Southeast Asia","volume":"12","author":"Wyres","year":"2020","journal-title":"Genome Med."},{"key":"ref_126","doi-asserted-by":"crossref","first-page":"460","DOI":"10.1080\/21505594.2016.1222343","article-title":"The global epidemiology of carbapenemase-producing Enterobacteriaceae","volume":"8","author":"Doi","year":"2017","journal-title":"Virulence"},{"key":"ref_127","unstructured":"European Centre for Disease Prevention and Control (2014). Systematic Review of the Effectiveness of Infection Control Measures to Prevent the Transmission of Carbapenemase-Producing Enterobacteriaceae Through Cross-Border Transfer of Patients."},{"key":"ref_128","doi-asserted-by":"crossref","unstructured":"Tiwari, A., Paakkanen, J., \u00d6sterblad, M., Kirveskari, J., Hendriksen, R.S., and Heikinheimo, A. (2022). Wastewater Surveillance Detected Carbapenemase Enzymes in Clinically Relevant Gram-Negative Bacteria in Helsinki, Finland; 2011\u20132012. Front. Microbiol., 13.","DOI":"10.3389\/fmicb.2022.887888"},{"key":"ref_129","doi-asserted-by":"crossref","first-page":"26576","DOI":"10.1038\/s41598-024-76824-w","article-title":"Detection of carbapenemases in Enterobacterales and other Gram-negative bacilli recovered from hospital and municipal wastewater in Mexico City","volume":"14","year":"2024","journal-title":"Sci. Rep."},{"key":"ref_130","unstructured":"European Commission (2026, May 25). EU Action on Antimicrobial Resistance. Available online: https:\/\/health.ec.europa.eu\/antimicrobial-resistance\/eu-action-antimicrobial-resistance_en."},{"key":"ref_131","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1186\/s12941-024-00762-8","article-title":"Tracing the transmission of carbapenem-resistant Enterobacterales at the patient: Ward environmental nexus","volume":"23","author":"Elton","year":"2024","journal-title":"Ann. Clin. Microbiol. Antimicrob."},{"key":"#cr-split#-ref_132.1","unstructured":"European Parliament, and Council of the European Union (2024). Directive"},{"key":"#cr-split#-ref_132.2","unstructured":"(EU) 2024\/3019 of the European Parliament and of the Council of 27 November 2024 concerning urban wastewater treatment (recast). Off. J. Eur. Union, L 2024\/3019. Available online: https:\/\/eur-lex.europa.eu\/eli\/dir\/2024\/3019\/oj."},{"key":"ref_133","doi-asserted-by":"crossref","first-page":"2500289","DOI":"10.2807\/1560-7917.ES.2026.31.3.2500289","article-title":"Integrating AMR surveillance into wastewater monitoring systems in 2025: A position on the implementation of Article 17 of the Urban Wastewater Treatment Directive (UWWTD)","volume":"31","author":"Hock","year":"2026","journal-title":"Euro Surveill."},{"key":"ref_134","unstructured":"Food and Agriculture Organization of the United Nations, United Nations Environment Programme, World Health Organization, and World Organisation for Animal Health (2022). One Health Joint Plan of Action (2022\u20132026): Working Together for the Health of Humans, Animals, Plants and the Environment, World Health Organization."},{"key":"ref_135","unstructured":"Franz, E. (2025). NethMap One Health 2025: Consumption of Antimicrobial Agents and Antimicrobial Resistance Among Medically Important Bacteria in the Netherlands in 2024."},{"key":"ref_136","unstructured":"Technical University of Denmark and Statens Serum Institut (2025). DANMAP 2024: Use of Antimicrobial Agents and Occurrence of Antimicrobial Resistance in Bacteria from Food Animals, Food and Humans in Denmark, Technical University of Denmark, National Food Institute and Statens Serum Institut."},{"key":"ref_137","unstructured":"Public Health Agency of Sweden, and National Veterinary Institute (SVA) (2025). Swedres-Svarm 2024: Sales of Antibiotics and Occurrence of Antibiotic Resistance in Sweden."},{"key":"ref_138","unstructured":"European Centre for Disease Prevention and Control (2026). Results from the Survey of Carbapenem- and\/or Colistin-Resistant Enterobacterales in Europe, 2019."},{"key":"ref_139","doi-asserted-by":"crossref","first-page":"101321","DOI":"10.1016\/j.lanmic.2025.101321","article-title":"Emergence of carbapenemase-producing Escherichia coli in acute care hospitals in 32 European countries (the CCRE survey): A prospective, multicentre, cross-sectional, epidemiological, microbiological, and genomic surveillance study","volume":"7","author":"David","year":"2026","journal-title":"Lancet Microbe"},{"key":"ref_140","unstructured":"European Centre for Disease Prevention and Control (2026, July 19). Europe Advances Genomic Surveillance of CCRE with Landmark Multi-Country Study. Available online: https:\/\/www.ecdc.europa.eu\/en\/news-events\/europe-advances-genomic-surveillance-ccre-landmark-multi-country-study."},{"key":"ref_141","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1016\/j.cmi.2023.12.011","article-title":"Optimizing infection control and antimicrobial stewardship bedside discussion: A scoping review of existing evidence on effective healthcare communication in hospitals","volume":"30","author":"Bonaconsa","year":"2024","journal-title":"Clin. Microbiol. Infect."},{"key":"ref_142","doi-asserted-by":"crossref","unstructured":"Schmid, S., Schlosser, S., G\u00fclow, K., Pavel, V., M\u00fcller, M., and Kratzer, A. (2022). Interprofessional Collaboration between ICU Physicians, Staff Nurses, and Hospital Pharmacists Optimizes Antimicrobial Treatment and Improves Quality of Care and Economic Outcome. Antibiotics, 11.","DOI":"10.3390\/antibiotics11030381"},{"key":"ref_143","doi-asserted-by":"crossref","first-page":"e51","DOI":"10.1093\/cid\/ciw118","article-title":"Implementing an Antibiotic Stewardship Program: Guidelines by the Infectious Diseases Society of America and the Society for Healthcare Epidemiology of America","volume":"62","author":"Barlam","year":"2016","journal-title":"Clin. Infect. Dis."},{"key":"ref_144","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1186\/s13756-024-01428-y","article-title":"Development and validation of machine learning models to predict MDRO colonization or infection on ICU admission by using electronic health record data","volume":"13","author":"Li","year":"2024","journal-title":"Antimicrob. Resist. Infect. Control"},{"key":"ref_145","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1017\/ice.2019.42","article-title":"Predicting probability of perirectal colonization with carbapenem-resistant Enterobacteriaceae (CRE) and other carbapenem-resistant organisms (CROs) at hospital unit admission","volume":"40","author":"Goodman","year":"2019","journal-title":"Infect. Control Hosp. Epidemiol."},{"key":"ref_146","doi-asserted-by":"crossref","first-page":"1240","DOI":"10.1016\/j.ajic.2018.05.001","article-title":"Development of a risk prediction model of carbapenem-resistant Enterobacteriaceae colonization among patients in intensive care units","volume":"46","author":"Song","year":"2018","journal-title":"Am. J. Infect. Control"},{"key":"ref_147","doi-asserted-by":"crossref","first-page":"0099","DOI":"10.34133\/hds.0099","article-title":"Detection of Patients at Risk of Multidrug-Resistant Enterobacteriaceae Infection Using Graph Neural Networks: A Retrospective Study","volume":"3","author":"Gouareb","year":"2023","journal-title":"Health Data Sci."},{"key":"ref_148","doi-asserted-by":"crossref","unstructured":"\u00c7a\u01e7layan, \u00c7., Barnes, S.L., Pineles, L.L., Harris, A.D., and Klein, E.Y. (2022). A Data-Driven Framework for Identifying Intensive Care Unit Admissions Colonized with Multidrug-Resistant Organisms. Front. Public Health, 10.","DOI":"10.3389\/fpubh.2022.853757"},{"key":"ref_149","doi-asserted-by":"crossref","first-page":"664","DOI":"10.1086\/511640","article-title":"Measurement of Adult Antibacterial Drug Use in 130 US Hospitals: Comparison of Defined Daily Dose and Days of Therapy","volume":"44","author":"Polk","year":"2007","journal-title":"Clin. Infect. Dis."},{"key":"ref_150","doi-asserted-by":"crossref","unstructured":"Abdelsalam Elshenawy, R., Umaru, N., and Aslanpour, Z. (2025). Development and Implementation of a Dynamic Antimicrobial Stewardship Dashboard: Real-Time Monitoring from \u2018Start Smart\u2019 to \u2018Then Focus\u2019. medRxiv.","DOI":"10.1101\/2025.09.10.25335122"},{"key":"ref_151","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1186\/s13063-025-09132-x","article-title":"Examining tailoring as an implementation strategy for reducing healthcare-associated infections across European acute care hospitals (REVERSE): Study protocol for a hybrid type 2 effectiveness-implementation trial","volume":"26","author":"Albers","year":"2025","journal-title":"Trials"},{"key":"ref_152","doi-asserted-by":"crossref","unstructured":"Svebrant, S., Sp\u00f6rndly, R., Lindberg, R.H., Olsen Sk\u00f6ldstam, T., Larsson, J., \u00d6hagen, P., Lindstr\u00f6m, H.S., and J\u00e4rhult, J.D. (2021). On-Site Pilot Testing of Hospital Wastewater Ozonation to Reduce Pharmaceutical Residues and Antibiotic-Resistant Bacteria. Antibiotics, 10.","DOI":"10.3390\/antibiotics10060684"},{"key":"ref_153","doi-asserted-by":"crossref","first-page":"11862","DOI":"10.1021\/acs.est.6b02640","article-title":"Inactivation of Antibiotic Resistant Bacteria and Resistance Genes by Ozone: From Laboratory Experiments to Full-Scale Wastewater Treatment","volume":"50","author":"Czekalski","year":"2016","journal-title":"Environ. Sci. Technol."},{"key":"ref_154","unstructured":"European Commission (2026, July 19). Pre-Commercial Procurement of Innovative and Sustainable Solutions to Treat Healthcare System Wastewater (THERESA PCP). Available online: https:\/\/cordis.europa.eu\/project\/id\/101226565."},{"key":"ref_155","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1016\/j.jinf.2022.04.028","article-title":"Fecal microbiota transplantation for Carbapenem-Resistant Enterobacteriaceae: A systematic review","volume":"84","author":"Dong","year":"2022","journal-title":"J. Infect."},{"key":"ref_156","doi-asserted-by":"crossref","unstructured":"Lee, J.-H., Shin, J., Park, S.-H., Cha, B., Hong, J.-T., Lee, D.-H., and Kwon, K.S. (2023). Role of Probiotics in Preventing Carbapenem-Resistant Enterobacteriaceae Colonization in the Intensive Care Unit: Risk Factors and Microbiome Analysis Study. Microorganisms, 11.","DOI":"10.3390\/microorganisms11122970"}],"container-title":["Antibiotics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2079-6382\/15\/8\/790\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T12:30:28Z","timestamp":1786969828000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2079-6382\/15\/8\/790"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8,15]]},"references-count":157,"journal-issue":{"issue":"8","published-online":{"date-parts":[[2026,8]]}},"alternative-id":["antibiotics15080790"],"URL":"https:\/\/doi.org\/10.3390\/antibiotics15080790","relation":{},"ISSN":["2079-6382"],"issn-type":[{"value":"2079-6382","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,8,15]]}}}